We work with founders to properly set up their companies; review business plans and identify companies' key strengths and weaknesses before approaching financing sources; license core technology; develop strategies to obtain funding and negotiate terms for initial and later-stage financings; prepare and implement key agreements with management, employees, consultants and advisors; design equity incentive plans; and advise clients on how best to achieve liquidity. We also attend board meetings and offer strategic advice and counseling on important business decisions, as well as guidance on forming and running an effective board of directors.
Our lawyers represent life sciences companies—including those in the biotechnology, medical device and healthcare sectors—as well as technology companies in a broad range of industries, including consumer Internet, fintech, energy, material science, cybersecurity, digital media, mobile technology, robotics, software, hardware, big data, and clean technology. In addition to our corporate experience, we are able to tap into the deep technical and scientific knowledge of our attorneys who hold degrees in fields such as biochemistry, biology, biomedical engineering, chemical engineering, chemistry, computer science, electrical engineering, genetics, immunology, information systems, mathematics, mechanical engineering, medicine, microbiology, organic chemistry and systems engineering. As a result, we have a sophisticated understanding of the important technical and intellectual property issues facing companies in these sectors.
Venture capital deals are a cornerstone of our practice, and reflect our longstanding focus on emerging technology and life sciences companies. In 2016, we served as counsel in approximately 250 venture financings raising nearly $3 billion, including some of the largest and most prominent deals of the year. Since 2006, we have handled more than 2,800 venture financings with total proceeds in excess of $35 billion. Learn more about our venture capital capabilities.